It's a serious side effect that can then lead to muscle breakdown, kidney failure and death.
Researchers reporting in "The New England Journal of Medicine" have identified a gene that helps predict a person's risk for this side effect.
The finding raises hopes that a test could be developed to screen heart patients to determine who might be a genetic risk.